Evolent Health
EVH
220 hedge funds and large institutions have $1.42B invested in Evolent Health in 2025 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 80 increasing their positions, 73 reducing their positions, and 41 closing their positions.
40% more call options, than puts
Call options by funds: $3.55M | Put options by funds: $2.53M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
19% more capital invested
Capital invested by funds: $1.19B → $1.42B (+$225M)
10% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 73
0.72% less ownership
Funds ownership: 107.92% → 107.2% (-0.72%)
7% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 41
3% less funds holding
Funds holding: 227 → 220 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$59M |
| 2 |
Morgan Stanley
New York
|
+$30.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.5M |
| 4 |
8KM
8 Knots Management
Dallas,
Texas
|
+$26.8M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
+$12.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$93.3M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$19.7M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$18.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.1M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$12.9M |
EVH Hedge Fund Activity: Q2 2025 in Review
220 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2025, worth a combined $1.42B — up 19% from $1.19B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of EVH and 38 opened new positions — a net loss of 3 holders — while 73 trimmed existing stakes and 80 added.
The largest buyer was Durable Capital Partners, opening a new position worth an estimated $59M. The largest seller was Wellington Management Group, cutting an estimated $93.3M.
- 220 institutional investors held Evolent Health (EVH) as of Q2 2025, down from 227 in Q1 2025.
- Funds reported $1.42B of Evolent Health stock for Q2 2025, up 19% quarter-over-quarter.
- 38 funds opened new Evolent Health positions in Q2 2025 and 41 closed out, a net change of -3 holders.
- The largest Evolent Health buyer in Q2 2025 was Durable Capital Partners, an estimated $59M added.
- The largest Evolent Health seller in Q2 2025 was Wellington Management Group, an estimated $93.3M sold.
Based on aggregated 13F filings for Q2 2025.